BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Entry into a Material Definitive Agreement

Item1.01 Entry into a Material Definitive Agreement

On February 10, 2017, BioLargo, Inc. (the Company) and its Chief
Financial Officer Charles K. Dargan, II formally agreed to extend
the engagement agreement dated February 1, 2008 (the Engagement
Agreement, which had been previously extended multiple times), to
which Mr. Dargan has been serving as the Companys Chief Financial
Officer. The Engagement Extension Agreement dated as of February
10, 2017 (the Engagement Extension Agreement) provides for an
additional term to expire September 30, 2017 (the Extended Term),
and is retroactively effective to the termination of the prior
extension on October 1, 2016.

Mr.Dargan shall be compensated through the issuance of an option
to purchase 300,000 shares of the Companys common stock, at a
strike price of $0.69 per share which is equal to the closing
price of the Companys common stock on February 10, 2017, to
expire February 10, 2027, and to vest over the term of the
engagement with 125,000 shares having vested as of February 10,
2017, and the remaining shares to vest 25,000 shares monthly
beginning March 1, 2017, and each month thereafter, so long as
this Agreement is in full force and effect.

Mr. Dargan will continue to be reimbursed for business expenses
he incurs in connection with the performance of his services as
the Companys Chief Financial Officer. All other provisions of the
Engagement Agreement not expressly amended to the Engagement
Extension Agreement remain the same, including provisions
regarding indemnification and arbitration of disputes.

Item 9.01 Financial Statements and Exhibits

About BioLargo, Inc. (OTCMKTS:BLGO)

BioLargo, Inc. is a provider of platform technologies. The Company’s products are used to eliminate contaminants that threaten the water, health and quality of life. Its technology has commercial applications within several industries. The Company focuses on four areas: water treatment; industrial odor control applications; commercial, household and personal care products (CHAPP), and advanced wound care. Its AOS Filter combines iodine, water filter materials and electrolysis within a water filter device. It generates oxidation potential in order to oxidize and breakdown or otherwise eliminate, soluble organic contaminant, which are found in contaminated water. Its CupriDyne formula is used to deliver iodine within products. The Isan System is an automated iodine dosing system, which features controlled measuring, flow control, dosing and iodine extraction and removal technology, as well as an automatic tracking system that delivers iodine in calibrated doses.

BioLargo, Inc. (OTCMKTS:BLGO) Recent Trading Information

BioLargo, Inc. (OTCMKTS:BLGO) closed its last trading session up +0.018 at 0.696 with 46,646 shares trading hands.